BioSpace News Archive

Our market experts have determined the current financial positions of the leading industry players in the report leveraging advanced analytical tools such as Porter’s Five Forces Analysis, SWOT analysis, and investment assessment.

The U.S. Biotechnology & Pharmaceutical Services Outsourcing market size was valued at US$ 4.1 billion in 2021 and is expected to hit US$ 6.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.2% from 2022 to 2030.

According to Report Study, the U.S. Clinical Trials market size was valued at US$ 23.1 billion in 2021 and is expected to hit US$ 35.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.2% from 2022 to 2030.

A New business Strategy report released by Data Bridge Market Research with title Global eHealth Market Study Forecast till 2029.

AACC is pleased to announce that Erika Cheung and Tyler Shultz—two of the key whistleblowers who helped bring down Theranos—will speak in a special fireside chat at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago.

Critical Path Institute (C-Path) and Replica Analytics, an Aetion company, announced today a new partnership that involves leveraging synthetic data to further catalyze the generation of actionable solutions to accelerate drug development for rare diseases.

IAMA Therapeutics, a preclinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel medicines to make a difference in the lives of individuals suffering from brain disorders, announced today it will present a poster at the upcoming International Neuroscience Conference of the Federation of the European Neuroscience Societies (FENS).

A New Business Strategy report released by Data Bridge Market Research with the title Global Internet of Medical Things (IoMT) Market Study Forecast till 2028.

ANGLE plc, a world-leading liquid biopsy company, announces that at the Annual General Meeting of the Company held earlier, all resolutions were duly passed.

As part of an enduring commitment to equipping surgeons in the federal healthcare system with the best tools possible, MellingMedical is pleased to provide access to the full suite offered by Fehling Surgical Instruments, Inc.